Abstract: A system may include a toy character, a viewing device, and system software. The viewing device may include a camera. The toy character may include a plurality of component parts and a plurality of augmented reality markers. At least two component parts of the plurality of component parts may each include at least one augmented reality marker of the plurality of augmented reality markers. The system software may be configured to validate a marker configuration defined by the plurality of augmented reality markers of the toy character, generate a single composite marker when the marker configuration is validated, track the toy character via the single composite marker, unlock features associated with the validated marker configuration, register the toy character to a user when the marker configuration is validated, and authorize the user to join a game upon registration of the toy character.

Abstract: The present invention relates to treatments of bradykinin-mediated angioedema. In particular, the present invention provides on-demand treatments of bradykinin-mediated angioedema by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand as an oral dosage form particularly suitable for patients who may struggle to swallow tablets.